A detailed history of Susquehanna Fundamental Investments, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 88,854 shares of BCRX stock, worth $804,128. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,854
Previous 30,176 194.45%
Holding current value
$804,128
Previous $186 Million 99.64%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.03 - $8.43 $412,506 - $494,655
58,678 Added 194.45%
88,854 $668,000
Q2 2024

Aug 15, 2024

SELL
$4.13 - $6.79 $141,200 - $232,143
-34,189 Reduced 53.12%
30,176 $186 Million
Q1 2024

May 07, 2024

BUY
$4.89 - $7.65 $314,744 - $492,392
64,365 New
64,365 $327 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.68B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.